Krsnaa Diagnostics Limited has announced the release of its Q2 financial results for the fiscal year ending September 30, 2025, which were made public on November 9, 2025. The results encompass both standalone and consolidated figures, reflecting the company's performance for the quarter and the half year. The financial disclosures are a requirement under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the company has ensured compliance by publishing advertisements in major newspapers, including the Financial Express and Loksatta.

Investors and stakeholders can access these financial results on the company's official website at www.krsnaadiagnostics.com/investors. The announcement was officially communicated to the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), with the scrip code 543328 and NSE symbol KRSNAA respectively. This transparency is crucial for maintaining investor confidence and upholding regulatory standards in the financial reporting landscape. The company’s commitment to clear communication underlines its dedication to its shareholders and the broader investment community.